Frequency of pharmacologic or mechanical thromboprophylaxis use by admission per age group
| . | Age 13-14 . | Age 15-17 . | Age 18-21 . |
|---|---|---|---|
| N = 7256 . | N = 14172 . | N = 12666 . | |
| Prophylaxis (pharmacological or mechanical) | 362 (5.0) | 865 (6.1) | 1373 (10.8) |
| Pharmacologic prophylaxis | 119 (1.6) | 333 (2.3) | 773 (6.1) |
| Enoxaparin | 113 (95.0) | 282 (84.7) | 670 (86.7) |
| Apixaban | 4 (3.4) | 55 (16.5) | 109 (14.1) |
| Rivaroxaban | 1 (0.8) | 3 (0.9) | 4 (0.5) |
| Fondaparinux | 0 (−) | 1 (0.3) | 0 (−) |
| Dabigatran | 1 (0.8) | 0 (−) | 0 (−) |
| Mechanical prophylaxis | 253 (3.5) | 569 (4.0) | 652 (5.1) |
| Compression sleeves for sequential device | 224 (88.5) | 495 (87.0) | 589 (90.3) |
| Sequential compression device | 29 (11.5) | 70 (12.3) | 58 (8.9) |
| Compression stockings | 5 (2.0) | 27 (4.7) | 29 (4.4) |
| . | Age 13-14 . | Age 15-17 . | Age 18-21 . |
|---|---|---|---|
| N = 7256 . | N = 14172 . | N = 12666 . | |
| Prophylaxis (pharmacological or mechanical) | 362 (5.0) | 865 (6.1) | 1373 (10.8) |
| Pharmacologic prophylaxis | 119 (1.6) | 333 (2.3) | 773 (6.1) |
| Enoxaparin | 113 (95.0) | 282 (84.7) | 670 (86.7) |
| Apixaban | 4 (3.4) | 55 (16.5) | 109 (14.1) |
| Rivaroxaban | 1 (0.8) | 3 (0.9) | 4 (0.5) |
| Fondaparinux | 0 (−) | 1 (0.3) | 0 (−) |
| Dabigatran | 1 (0.8) | 0 (−) | 0 (−) |
| Mechanical prophylaxis | 253 (3.5) | 569 (4.0) | 652 (5.1) |
| Compression sleeves for sequential device | 224 (88.5) | 495 (87.0) | 589 (90.3) |
| Sequential compression device | 29 (11.5) | 70 (12.3) | 58 (8.9) |
| Compression stockings | 5 (2.0) | 27 (4.7) | 29 (4.4) |